본문 바로가기

Exploring Microalgae as a Novel Resource for Hepatocellular Carcinoma Therapy

문서 유형
연구출판물 · 리뷰논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
MOLECULES31(6) · 2026
피인용
Web of Science 2Scopus 2
FWCI (Scopus)
0.57
JCR IF
JCR 2024 4.6
ISSN
1420-3049

저자

  1. 윤식제1저자Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 50612, South Korea
  2. Tan, Kok KeongUniv Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Pokfulam, Hong Kong, Peoples R China
  3. 송원훈Pusan Natl Univ, Sch Med, Dept Urol, Yangsan 50612, South Korea
  4. 김창원Pusan Natl Univ, Sch Med, Dept Radiol, Yangsan 50612, South Korea
  5. Bay, Boon HuatNatl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117594, Singapore
  6. 오세옥교신저자Pusan Natl Univ, Sch Med, Dept Anat, Yangsan 50612, South Korea

초록

Hepatocellular carcinoma (HCC) remains a major cause of cancer-related mortality in the world. Although there is an armamentarium of therapeutic options available for HCC therapy, current treatment modalities still face challenges, such as limited effectiveness and resistance to therapy due to inherent intratumoral heterogeneity. Hence, the development of novel therapeutics is an unmet need. Microalgae possess the ability to provide naturally derived compounds that are attractive for biomedical applications. The multifunctional nature of microalgae, with its unique combination of anticancer metabolites, oxygen-generating capability, and photosensitizing activity, make them a versatile platform for developing next-generation cancer therapeutics. In light of the above, this succinct narrative review highlights the potential biomedical applications of microalgae in cancer therapy, with a focus on HCC. Preclinical studies have shown the significant potential of microalgae as naturally occurring sources of chemopreventive and anticancer agents against HCC. Future directions include the use of biotechnology to enhance the production of microalgal-derived bioactive compounds and the formulation of biocompatible and biodegradable drug–microalgae embolic agents with prolonged release of anticancer drugs, thereby giving rise to synergistic antitumor effects, and their application for the delivery of immune checkpoint inhibitors for immunotherapy in HCC. Overall, microalgae hold considerable promise for advancing innovative therapeutic strategies against HCC.

키워드

anticancer agentschemopreventionembolizing agents for transarterial chemoembolizationhepatocellular carcinomamicroalgae-derived bioactive compoundssynergistic antitumor effects

식별자

Scopus EID
2-s2.0-105034313897
WoS UID
001725974700001